Medicinal plants have been conventionally used to sustain health and for the treatment of many diseases such as diabetes. Spinacia oleracea L., common name palak, belong to the class Amaranths and family Amaranthaceous. It is used as an anti-bacterial, antidiabetic, anticancer, anti-inflammatory, antioxidant, and hepatoprotective agent. In this study, methanol, ethanol, n-hexane and aqueous extracts of the S. oleracea leaf were used to evaluate antioxidant contents, antioxidant activity, antidiabetic activity (inhibition of glycation, alpha amylase, alpha glucosidase, acetylchlinesterase). Additionally, identification of bioactive compounds and functional groups was done by Fourier transform infrared spectroscopy (FTIR) and high performance liquid chromatography (HPLC). Among all the extracts, total phenol and flavonoid contents ranged from 32.09 ± 0.99 g GAE/100 g to 78.38 ± 1.15 g GAE/100 g and 22.77 ± 0.16 g CE/100 g to 54.56 ± 0.87 g CE/100 g respectively. While DPPH reducing activity range was 45.14% -75.77%. Methanol extract was most potent as it extracted maximum antioxidant contents. Glycation and alpha amylase inhibition percentages were 15.31 to 34.28 and 19.83-36.32 among all tested samples. Whereas, 12.67% - 43.77% and 17.3% -28.04% inhibitions of alpha glucosidase and acetylcholinesterase activities were observed respectively. HPLC analysis identified various flavonoids and phenolics acids such as quercetin, gallic acid, caffeic acid, sinopic acid, cinnamic acid. FTIR revealed the presence of several phenols, amines, alkaloids, alcohols and fluoro compounds in the meth-anolic leaves extract. This research indicated that S. oleracea has wide potential to be further investigated in the future and it can prove as a wonderful natural drug for healthcare systems in the upcoming years.